DBV Technologies | Egenkapital Og Reserver



Equity Capital And Reserves Lave om Dato
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Alnylam Pharmaceuticals USD 67.09M 34.73M 2024-12
Amarin USD 531.38M 20.5M 2024-09
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
DBV Technologies USD 54.03M 25.06M 2024-09
Halozyme Therapeutics USD 363.82M 88.88M 2024-12
Incyte USD 3.45B 276.41M 2024-12
Insmed USD 285.38M 198.04M 2024-12
Ionis Pharmaceuticals USD 588.35M 74.12M 2024-12
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
PTC Therapeutics USD -1098071000 43.72M 2024-12
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
United Therapeutics USD 6.44B 343.1M 2024-12



DBV Technologies Egenkapital Og Reserver - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.